15:30 – 17:00                                                                       JUNE 12, 2019
SPIRU HARET Hall

The latest developments and challenges in application of nanotechnology to achieve innovation in pharmaceutical healthcare, generally referred as nano-medicine, will be discussed during this session. It will address how to achieve a faster, more successful industrialisation and uptake of new nanomedicine, and nanopharmaceutical upscaling and the regulatory approval aspects will be specifically analysed.

MODERATOR:

Patrick Boisseau, Chairman of the European Technology Platform on Nanomedicine, VP Europe at CEATech Healthcare Institute, based in Grenoble, France

INVITED SPEAKERS:

Patrick Boisseau, Chairman of the European Technology Platform on Nanomedicine, VP Europe at CEATech Healthcare Institute, France
Boost your nanomedicine development with the nanomedicine translation hub (presentation 1)
EUNCL Infrastructure: your gateway to the regulatory approval of your nanopharmaceuticals (presentation 2)

Iraida Loinaz, Director of CIDETEC Nanomedicine Institute, Spain
NANOPILOT: A specialized plant for the production of Nanopharmaceuticals

Oihane Ibarrola, Praxis Biopharma Research Institute, Spain
Open Innovation Test Bed for the nanomedical devices

Blanka Halamoda-Kenzaoui, EC Directorate General Joint Research Centre Ispra, Italy
The Regulatory Science Framework in nanomedicine: how science could improve the implementation of regulation?

MODERATOR:

KEYNOTE SPEAKERS (in alphabetical order)